Predictors of Pneumonitis in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation Followed by Consolidative Durvalumab

PURPOSE: In patients with locally advanced, unresectable non-small cell lung cancer (NSCLC), the standard of care is concurrent chemoradiation (CRT) followed by consolidative immunotherapy with durvalumab. Pneumonitis is a known adverse event of both radiation therapy and immune checkpoint inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Diamond, Brett H., Belani, Neel, Masel, Rebecca, DeCarli, Kathryn, DiPetrillo, Thomas, Hepel, Jaroslaw T., Azzoli, Christopher G., Khurshid, Humera, Abbas, Abbas, Koffer, Paul P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Scientific Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9943772/
https://www.ncbi.nlm.nih.gov/pubmed/36845618
http://dx.doi.org/10.1016/j.adro.2022.101130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9943772/
https://www.ncbi.nlm.nih.gov/pubmed/36845618
http://dx.doi.org/10.1016/j.adro.2022.101130

Ejemplares similares